104 results on '"Drugs -- Economic aspects"'
Search Results
2. Study Results from Aristotle University Provide New Insights into Drugs and Therapies (Valorization of Peach By-Products: Utilizing Them as Valuable Resources in a Circular Economy Model)
3. Study Data from Sichuan University Update Knowledge of Rare Diseases and Conditions (Budget impact analysis of high-priced orphan medicinal products intended for the treatment of rare diseases in China: evidence from a densely populated ...)
4. Digbi Health Selected by State Public Health Insurance Trust to Manage Obesity Treatment Costs Amid Escalating GLP-1 Drug Expenses
5. Studies from Xi'an Yield New Data on Pharmacology (The Impact of a National Stewardship Policy on the Usage Patterns of Key Monitoring Drugs in a Tertiary Teaching Hospital: An Interrupted Time Series Analysis)
6. Researchers' Work from Aristotle University of Thessaloniki Focuses on Drug Targets (Drug-target Interaction Prediction Via an Ensemble of Weighted Nearest Neighbors With Interaction Recovery)
7. Kalderos' 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients
8. Research from Partners In Health Yields New Findings on Global Health (Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts)
9. Study Findings on Drugs and Therapies Are Outlined in Reports from Bayer AG (Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile)
10. Researchers at University of Dundee Have Reported New Data on Psoriasis (Phototherapy achieves significant cost savings by the delay of drug-based treatment in psoriasis)
11. Findings from King Faisal Specialist Hospital and Research Center Provides New Data about Anesthesiology (Cost drain of anesthesia emergency drugs in a quaternary care hospital)
12. Findings from RTI International in Hepatitis Reported (Cost-Effectiveness of Scaling Up HCV Prevention and Treatment in the United States for People Who Inject Drugs)
13. Reports from Durham Veterans Affairs Health Care System Advance Knowledge in Pharmacy Practice (Assessing the Economic Value of Pharmacy Resident Participation in an Investigational Drug Service)
14. Lyfegen Raises $8 Million to Drive Down Drug Costs and Help Patients Access Life-Saving Medications
15. Removing globally-used anxiety drug from recycled and wastewater at low cost
16. McMaster University engineers make drug testing more efficient and affordable
17. Data on Health and Medicine Discussed by Researchers at University of Pennsylvania (Cost-effectiveness Analysis of Branded Drugs With Market Demand and Insurance)
18. Three Harvard experts explain how economics can shape precision medicines
19. Findings from Novartis Pharmaceuticals Corporation Reveals New Findings on Health and Society (Quantifying the Economic Burden of Drug Utilization Management On Payers, Manufacturers, Physicians, and Patients)
20. Investigators from Northwestern University Release New Data on Economic Policy (Preferred Pharmacy Networks and Drug Costs)
21. New Findings from University of Toulouse Capitole Update Understanding of European Economies (Pooled Procurement of Drugs In Low and Middle Income Countries)
22. Targeted therapy drugs could radically increase the costs of leukemia treatment
23. U.S. Workers' Compensation Prescription Drug Spending Increased 2.2 Percent in 2015
24. Relative expected value of drugs versus competing rewards underpins vulnerability to and recovery from addiction (Updated November 3, 2020)
25. Data on Personalized Medicine Reported by Researchers at Cancer Institute (Economic perspective of cancer treatment in India)
26. Otsuka America Pharmaceutical, Inc. Provides Eligible, Newly Uninsured Patients in the U.S. With No-Cost Access to Its Medicines
27. As out-of-pocket costs for neurologic medications rise, people less likely to take them
28. Expensive drugs that cure hepatitis C are worth the cost, even at early stages of liver fibrosis
29. SingleCare Teams up With Martin Sheen in National TV Advertising Campaign to Show Americans How They Can Save Money on Prescription Drugs
30. Biosimilar drugs can reduce costs but still face challenges in the US
31. Apex Benefits Hosts High-Cost Medications Event to Feature Lilly, Cigna and Swiss Re Executives
32. Studies from Brookhaven National Laboratory Further Understanding of Personalized Medicine (Economics of New Molecular Targeted Personalized Radiopharmaceuticals)
33. Investigators from University of Michigan Have Reported New Data on Multiple Sclerosis (Out-of-pocket Costs Are On the Rise for Commonly Prescribed Neurologic Medications)
34. AscellaHealth Supports Skin Cancer Awareness Month, Optimizes Plan Member Drug Therapy on Day One to Improve Outcomes, Lower Costs
35. Out-of-pocket costs for neurologic medications rise sharply over 12 years
36. NICE guidelines ration affordable osteoporosis drugs
37. Findings from J. Voigt et al Update Understanding of Antidepressants (Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder ...)
38. Celltrion taps Oracle Health Sciences Safety Solutions to Help Bring Cost-Effective Life-Saving and Biosimilar Drugs to Market
39. Agragen Engineers Camelina to Produce a Biological Pharmaceutical for Treating Inflammatory Diseases to Dramatically Reduce the Costs for This Popular Drug
40. Data from A. Garcia-Sempere and Colleagues Advance Knowledge in Heart Disease (Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome)
41. New Asthma Study Results Reported from A. Manfrin et al [A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients]
42. Studies from University of Pennsylvania Have Provided New Data on Health and Medicine (The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems)
43. Reports from F.A. da Costa and Colleagues Advance Knowledge in Clinical Pharmacy (Effects of economic recession on elderly patients' perceptions of access to health care and medicines in Portugal)
44. Investigators from University of Kentucky Zero in on Critical Care Medicine (Managing the Rising Costs and High Drug Expenditures in Critical Care Pharmacy Practice)
45. Reports from University of Witwatersrand Advance Knowledge in Antiretrovirals (Cutting the cost of South African antiretroviral therapy using newer, safer drugs)
46. Investigators from American College of Physicians Have Reported New Data on Internal Medicine (Stemming the Escalating Cost of Prescription Drugs: A Position Paper of the American College of Physicians)
47. AstraZeneca Introduces AZhelps, an Innovative Savings and Support Program to Help Patients with Their Medicines
48. Investigators from RAND Zero in on Multiple Sclerosis (Impact of Cost Sharing on Specialty Drug Utilization and Outcomes: A Review of the Evidence and Future Directions)
49. LSTM's health economists call for strategies for universal access to medicines
50. Data from University of Orleans Advance Knowledge in Clinical Pharmacy (Computer-assisted management of unconsumed drugs as a cost-containment strategy in oncology)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.